Impact of albumin on drug delivery--new applications on the horizon.
about
Albumin-based drug delivery: harnessing nature to cure diseasePlasma proteins interaction with curcumin nanoparticles: implications in cancer therapeuticsUnraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based TherapeuticsCys34-PEGylated Human Serum Albumin for Drug Binding and DeliveryAn in vitro and in vivo study of gemcitabine-loaded albumin nanoparticles in a pancreatic cancer cell line.Structural basis of non-steroidal anti-inflammatory drug diclofenac binding to human serum albuminThe neonatal Fc receptor, FcRn, as a target for drug delivery and therapyIn vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug deliverySimple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapySite-specific albumination of a therapeutic protein with multi-subunit to prolong activity in vivoBovine serum albumin nanoparticles as controlled release carrier for local drug delivery to the inner ear.Novel flower-shaped albumin particles as controlled-release carriers for drugs to penetrate the round-window membrane.First-in-human, phase I/IIa dose-escalation and safety study of balugrastim in breast cancer patients receiving myelosuppressive chemotherapy.Extending serum half-life of albumin by engineering neonatal Fc receptor (FcRn) binding.In situ preparation of water-soluble ginsenoside Rh2-entrapped bovine serum albumin nanoparticles: in vitro cytocompatibility studies.Genome-Wide Identification and Comparative Analysis of Albumin Family in Vertebrates.Preoperative neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for operable breast cancer: a multicenter phase II trial.Photothermal-chemotherapy with doxorubicin-loaded hollow gold nanospheres: A platform for near-infrared light-trigged drug release.The dual PI3K/mTOR inhibitor NVP-BEZ235 enhances nab-paclitaxel antitumor response in experimental gastric cancer.Intranasal administration as a route for drug delivery to the brain: evidence for a unique pathway for albumin.Nanopharmaceuticals (part 1): products on the market.Selective delivery of interleukine-1 receptor antagonist to inflamed joint by albumin fusion.Superior antitumor activity of nanoparticle albumin-bound paclitaxel in experimental gastric cancer.Efficacy of combined therapy with paclitaxel and low-level ultrasound in human chronic myelogenous leukemia cell line K562.Green synthesis and characterization of hybrid collagen-cellulose-albumin biofibers from skin waste.Investigation of cyanine dyes for in vivo optical imaging of altered mitochondrial membrane potential in tumors.Targeted Delivery of 5-fluorouracil with Monoclonal Antibody Modified Bovine Serum Albumin Nanoparticles.Albumin nanoparticles increase the anticancer efficacy of albendazole in ovarian cancer xenograft modelPolymer-albumin conjugate for the facilitated delivery of macromolecular platinum drugs.Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative DiseasesSpontaneous CO release from Ru(II)(CO)2-protein complexes in aqueous solution, cells, and miceIn Vivo Labeling of Serum Albumin for PET.Intrahepatic cholangiocarcinoma and gallbladder cancer: distinguishing molecular profiles to guide potential therapy.Variant fatty acid-like molecules Conjugation, novel approaches for extending the stability of therapeutic peptides.Human Serum Albumin-Delivered [Au(PEt3)]+ Is a Potent Inhibitor of T Cell Proliferation.The study on the preparation and characterization of gene-loaded immunomagnetic albumin nanospheres and their anti-cell proliferative effect combined with magnetic fluid hyperthermia on GLC-82 cellsThe protein binding substance ibuprofen does not affect the T1 time or partition coefficient in contrast-enhanced cardiovascular magnetic resonanceInaccuracies of nitric oxide measurement methods in biological media.Biopolymer-based nanoparticles for drug/gene delivery and tissue engineering.Vascular Accessibility of Endothelial Targeted Ferritin Nanoparticles.
P2860
Q26765789-3E7ED20B-41C6-4C4E-AE3D-36647165E8C2Q27026623-68565331-3ED7-4802-BECE-059EF199EFDBQ27027238-D0C89889-290E-4B33-A580-C6705D600F5AQ27301475-2016C71F-0934-4326-8417-3238ECD7A238Q27336445-6D088C5C-2C6F-49E7-BC2F-F32CF8AAF1ACQ27700781-5196A19C-A23D-45CE-A3C8-1AC7D6FD8E43Q28257521-1DD751B2-CF93-4845-8C85-0E22B5CC9DB2Q28396006-9AF75F41-B166-4BFA-988E-FFCE81997BE1Q28397980-D4677DE7-4226-4E62-A5ED-5BC22B15EDD9Q30300201-11E5A4EA-C234-46CB-9E21-CBA92BD1669EQ30433180-DD2FE1AA-6F4E-4116-8E83-5A549695191BQ30434310-F46B14A2-D8C1-4DB6-80F1-2FD6D8C8A533Q33420907-B733A8B1-2AAD-40A8-9DD2-3ACF7AA632D1Q33676732-4971687C-E26F-437B-B75E-AD79C405D544Q33758252-A65D2832-27A7-4459-B097-A60726D2652FQ33824988-E799EF69-7620-4D7A-88A5-DFAFF68FD6CCQ33844469-D7582D35-69C3-4741-BC91-7DC42C9E7A9CQ34069157-07877470-F72E-4151-BA8C-EC4AA91C40F2Q34086875-3940798D-272D-4C63-98C5-EF365CFD8A0FQ34186253-931118FA-CBFA-419C-8EDB-D5AC26D1743AQ34230175-5D93670A-CFA4-4817-99AF-E4784EB93881Q34420356-F66C0A21-16EF-4017-9B47-BB7AEFAA229CQ34608899-137327FC-9AD4-488A-AD65-9CEE3510D74DQ34953043-7FE4F33F-9853-4DF5-A89E-1591E4173ABBQ34959942-882DBE42-4918-4059-8271-99C9528794FAQ35000393-2F4BAAFA-F56F-449D-875B-192FEBB9B5EDQ35483911-B6389EF5-51C6-46D5-8103-8BA9AEAA2ADFQ35538164-09607638-2ED5-4C55-AB67-229F106C433DQ35581377-A8103EA0-4EB1-40B8-A933-EF12ED2ECBFAQ35768362-30A31BD8-564E-418E-A114-2915ACCD8622Q35863628-194E3CB2-CA17-41E4-A3B4-B9820AB5D166Q36078212-3325E638-5EF0-4CCE-8B73-06C6949D78DBQ36278688-F276F40D-81A2-4959-A72E-C75364B35548Q36363950-F80927CE-6A9C-4814-905B-3F59D68CC134Q36376153-93DB05E7-9FBF-4C81-92A4-839635004F48Q36394519-D9CEA0A7-BE61-4C7A-8FC8-C5546D87E70AQ36406587-1271908F-C79B-4B06-9B8B-F11AA03B86EBQ36589147-E3CED561-97AC-4911-B75B-58CAD372C66BQ36590092-E7BE9DF4-1A60-49E0-B172-7B7761F37A7FQ36693096-36B0156B-1FA9-4364-BBB6-A80E0D0F850E
P2860
Impact of albumin on drug delivery--new applications on the horizon.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Impact of albumin on drug delivery--new applications on the horizon.
@ast
Impact of albumin on drug delivery--new applications on the horizon.
@en
Impact of albumin on drug delivery--new applications on the horizon.
@nl
type
label
Impact of albumin on drug delivery--new applications on the horizon.
@ast
Impact of albumin on drug delivery--new applications on the horizon.
@en
Impact of albumin on drug delivery--new applications on the horizon.
@nl
prefLabel
Impact of albumin on drug delivery--new applications on the horizon.
@ast
Impact of albumin on drug delivery--new applications on the horizon.
@en
Impact of albumin on drug delivery--new applications on the horizon.
@nl
P1476
Impact of albumin on drug delivery--new applications on the horizon
@en
P2093
Felix Kratz
P356
10.1016/J.JCONREL.2011.09.069
P407
P577
2011-09-16T00:00:00Z